The present invention discloses synergistic nutraceutical or pharmaceutical or dietary supplement anti-inflammatory compositions comprising therapeutically effective combination of an extract selectively enriched in 3-O-acetyl-11-keto-.beta.-boswellic acid (AKBA) derived from Boswellia serrata and Boswellia serrata non- acidic resin extract (BNRE). The composition(s) can be used to prevent, control and treat inflammation and several inflammatory related diseases including asthma, osteoarthritis, rheumatoid arthritis, endothelial dysfunction and the like. The invention further discloses the amelioration of pro-inflammator biomarker proteins or molecules, whose expression/production is altered during inflammatory diseases.

Gokaraju; Ganga Raju

Gokaraju; Rama Raju

Gokaraju; Venkata Kanaka Ranga Raju

Golakoti; Trimurtulu

Bhupathiraju; Kiran

Alluri; Venkata Krishna Raju

Laila Nutraceuticals

Synergistic anti-inflammatory compositions comprising Boswellia serrata extracts

Compositions are described including a synergistic combination of hydroxytyrosol and 3-O-acetyl-11-keto-.beta.-boswellic acid. The hydroxytyrosol may be sourced from an olive extract and the 3-O-acetyl-11-keto-.beta.-boswellic acid may be sourced from a Boswellia serrata extract. The compositions may be formulated for oral administration to a mammalian or an avian subject. Methods for treating, repairing, or reducing damage to connective tissue caused by one or more inflammatory mediators and for reducing levels of one or more inflammatory mediators in connective tissue are provided, the methods comprising orally administering the compositions to a subject in need thereof.

3 o acetyl 11 keto beta boswellic acid/boswellia serrata

Synergistic anti-inflammatory compositions comprising Boswellia serrata extracts

Compositions comprising hydroxytyrosol and boswellic acid

Il database di erbe medicinali più completo supportato dalla scienza